Ascend Cannabis pulled $43.5M in online revenue over 90 days, with 54% of that coming from organic search. The fix wasn't a rebrand or a viral campaign. They replaced their iframe dispensary menu with indexable product pages, and organic traffic jumped 49%.
That's the reality of cannabis digital marketing right now: the biggest wins come from fixing technical problems that exist because the industry's default tools weren't built for search visibility. Most dispensaries are running Dutchie, Jane, or Weedmaps embedded menus. Google can't index iframe content against the parent domain. So the dispensary's product catalog, often hundreds of SKUs, is invisible to search engines.
Why can't cannabis brands run normal digital ads?
Every other industry starts with paid media and layers organic on top. Cannabis can't. Google Ads prohibits THC product promotion. Meta blocks it. Even CBD requires LegitScript certification plus written Meta authorization to run on Facebook and Instagram, and that only covers CBD, not THC.
The platform restrictions break down like this:
| Platform | THC products | CBD products | Hemp-derived THC |
|---|---|---|---|
| Google Ads | Blocked | Restricted (topical CBD in some states) | Blocked |
| Meta (Facebook, Instagram) | Blocked | Allowed with LegitScript cert + Meta authorization | Grey area, enforcement inconsistent |
| Programmatic display | Limited to cannabis-specific networks | Available through most DSPs | Available through most DSPs |
| Weedmaps | Full advertising available | N/A | N/A |
| Fully allowed (own your list) | Fully allowed | Fully allowed | |
| SEO and organic | Fully allowed | Fully allowed | Fully allowed |
On December 18, 2025, Trump signed an executive order directing DEA reclassification of cannabis to Schedule III. But that reclassification hasn't been finalized as of April 2026. And even after finalization, don't expect Google or Meta to flip a switch.
Ad platform policy changes typically lag regulatory changes by 12-24 months. Schedule III won't automatically open paid channels.
Multi-state operators are already adapting. Several MSOs are pivoting to hemp-derived THC products specifically because hemp slips through federal ad policy filters. It's a workaround, and regulators are watching, but for now it's a real channel.
What's the biggest technical SEO mistake dispensaries make?
The iframe menu problem. It's everywhere.
Dutchie, Jane, and Weedmaps all provide embedded menu systems that load inside an iframe on the dispensary's website. The menus look fine to customers. But to Googlebot, the iframe is a black box. The product names, descriptions, pricing, strain information, none of it gets associated with the dispensary's domain.
The Ascend Cannabis case proved the size of this gap. Fixing the iframe problem and building indexable product pages drove 49% more organic traffic and generated $43.5M in revenue over a single quarter. That's not incremental improvement. That's an entirely different business.
Google Business Profile adds another layer of limitation. Cannabis businesses get stripped of several standard GBP features. No offers, no events, no product listings, no Google Posts. The business category must be set to "Cannabis store," and that category comes with restrictions that other retail categories don't face.
The technical SEO checklist for dispensaries:
- 1Replace iframe menus with server-rendered product pages. Each product (or at minimum, each category) needs its own indexable URL.
- 2Implement proper schema markup (Product, LocalBusiness, FAQPage) rendered server-side, not injected via JavaScript.
- 3Optimize Google Business Profile within the allowed features: photos, reviews, hours, description. Post updates to your website instead of GBP.
- 4Build location-specific landing pages for each store with unique content, not templated copies.
- 5Own your backlink profile. Get listed on cannabis directories, local business directories, and industry publications.
Where do dispensary customers actually come from online?
The two dominant cannabis marketplaces tell different stories. Weedmaps pulls roughly 6.2 million monthly visits, and that traffic is overwhelmingly transaction-intent. People on Weedmaps are ready to buy. Leafly draws about 7.5 million monthly visits, but skews toward strain research and top-of-funnel discovery.
The mistake most dispensaries make is treating marketplace listings as their entire digital strategy. Weedmaps and Leafly are rent, not equity. You're paying for visibility on someone else's platform. When they change their algorithm or pricing, your traffic changes with it.
The dispensaries growing fastest are building owned channels:
- SEO-driven product and education pages on their own domain
- Email lists (fully legal, no platform risk)
- SMS marketing (with proper opt-in compliance)
- Local content targeting "[city] dispensary" and related queries
New York is an interesting case study in market velocity. The state went from 261 licensed adult-use dispensaries in 2024 to 556 by November 2025.
That kind of competition makes organic visibility a survival issue, not a nice-to-have. The dispensaries that invested in SEO before competition saturated are now sitting on domain authority that new entrants will spend years trying to match.
What compliance rules actually matter for marketing?
Cannabis marketing compliance isn't abstract. It's specific, it changes by state, and getting it wrong is expensive.
California's Department of Cannabis Control issued 34 recalls covering 444 products in Q2 2025 alone. Of those, 181 were tied to marketing and labeling violations, specifically packaging and branding deemed "attractive to children.
" California also enforces an audience composition rule: cannabis ads can only run on platforms or in media where 71.6% or more of the audience is verified as 21+.
New York's Office of Cannabis Management updated its rules in December 2025 to permit coupons, loyalty points, BOGO deals, and rewards programs. That's a significant shift. Before that update, most promotional tactics available to normal retailers were off-limits for cannabis businesses in New York.
On the data privacy side, Washington's My Health My Data Act now classifies cannabis purchase behavior as "consumer health data." That means cannabis retailers in Washington face healthcare-level data protection requirements for customer purchase histories, loyalty program data, and online browsing behavior on dispensary websites.
The FTC's 2025 Hemp Marketing Playbook applies to any business making product claims about hemp or cannabis products. The core requirement: substantiate every product claim with high-quality scientific support. "Helps with anxiety" or "promotes better sleep" without clinical backing is a violation. The FTC is actively enforcing.
Key compliance rules by state:
| State | Age-gating requirement | Promotional restrictions | Data privacy |
|---|---|---|---|
| California | 71.6% audience must be 21+ | No "attractive to children" imagery or branding | Standard CCPA |
| New York | 21+ verification required | Coupons, loyalty, BOGO now permitted (Dec 2025) | Standard |
| Washington | 21+ verification required | Standard restrictions | Purchase data classified as health data |
| Colorado | 71.6% audience must be 21+ | No price-based advertising on broadcast | Standard |
How does Instagram actually treat cannabis accounts?
Instagram's enforcement goes beyond the official policy. Even accounts that stay within the published rules experience what's effectively a shadow-reach penalty. The algorithm demotes cannabis-adjacent text, hashtags, and imagery in compliant accounts. Your posts show up. They just don't get distributed.
The result: cannabis brands on Instagram see engagement rates well below industry averages for comparable follower counts. The platform isn't banning the content. It's quietly reducing its reach. Building an audience on Instagram isn't impossible, but treating it as a primary growth channel for a cannabis brand is a losing strategy.
Better bets for organic social reach:
- YouTube: educational content about strains, consumption methods, and industry news performs well. YouTube's content policies are more permissive than Meta's for cannabis.
- Reddit: community engagement in relevant subreddits drives referral traffic. No advertising, but genuine participation builds brand recognition.
- Email newsletters: zero platform risk, direct relationship with your audience, and legal for cannabis content in all states.
What should a cannabis brand's marketing budget prioritize?
If you're spending $10K-$30K per month on marketing for a dispensary or cannabis brand, here's the allocation that produces the most compounding value:
- 1Technical SEO and content (40-50%): Fix the iframe problem, build indexable pages, create location and strain content. This is the highest-ROI channel because the competition is technically weak and the traffic is free after the initial investment.
- 2Email and SMS (15-20%): Build the list. Segment by purchase behavior. Automate welcome sequences, restock reminders, and new product announcements.
- 3Marketplace optimization (15-20%): Weedmaps and Leafly profiles, reviews, menu management. This is rent, but it drives immediate revenue.
- 4Brand content and social (10-15%): YouTube education, photography, community engagement. Long game.
- 5Compliance and legal review (5-10%): Every campaign, every product description, every ad. Non-negotiable.
Editor's Note: The dispensaries that grew fastest in 2025 didn't find a secret advertising loophole. They built organic machines while everyone else waited for paid channels to open up.
FAQ
No. Google Ads prohibits promotion of THC products. CBD products face heavy restrictions, with topical CBD permitted in some states. Even after the December 2025 executive order directing Schedule III reclassification, Google hasn't changed its ad policies. Expect a 12-24 month lag between regulatory finalization and platform policy updates.
Most dispensaries use Dutchie, Jane, or Weedmaps embedded menus that load in iframes. Google can't index iframe content against the parent domain, making the dispensary's entire product catalog invisible to search engines. Ascend Cannabis saw a 49% traffic increase and $43.5M in 90-day revenue after replacing their iframe menu with indexable product pages.
Not yet. Trump signed an executive order on December 18, 2025 directing DEA reclassification, but it hasn't been finalized as of April 2026. Even after finalization, Google and Meta policy changes historically lag regulatory shifts by 12-24 months. Don't plan your media budget around a policy change that hasn't happened.
Yes, with restrictions. CBD brands need LegitScript certification and written authorization from Meta. Only CBD products qualify, not THC. The approval process takes several weeks, and products must be topical or ingestible CBD specifically, with no therapeutic claims.
Washington's My Health My Data Act classifies cannabis purchase behavior as "consumer health data," requiring healthcare-level data protection. California's CCPA applies standard consumer privacy rules. The FTC's 2025 Hemp Marketing Playbook requires scientific substantiation for any product claims, with active enforcement underway.
New York had 556 licensed adult-use dispensaries by November 2025, more than double the 261 operating in 2024. That growth rate makes organic search visibility a competitive necessity, not a long-term project to get around to eventually.